Lidocaine Hydrochloride Injection shortage
Current 67 presentations · 10 manufacturers · first FDA posting 2012-02-22 · last update 2026-10-15
Manufacturers: Amphastar Pharmaceuticals, Inc., Anthea Pharma, B. Braun Medical Inc., Baxter Healthcare, Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Huons Co., Ltd. (South Korea), Spectra Medical Devices, LLC
Stated reasons (per FDA): Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Amphastar Pharmaceuticals, Inc. | Current Available |
— | Posted 02/22/2012 Updated 10/05/2026 | |
| Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Anthea Pharma | Current Available |
— | Distributed by Avenacy, LLC | Posted 02/22/2012 Updated 10/05/2026 |
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | B. Braun Medical Inc. | Current Available |
— | Posted 10/25/2017 Updated 10/07/2026 | |
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | B. Braun Medical Inc. | Current Available |
— | Posted 10/25/2017 Updated 10/07/2026 | |
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | B. Braun Medical Inc. | Current Available |
— | Posted 10/25/2017 Updated 10/07/2026 | |
| Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Baxter Healthcare | Current Available |
— | Posted 10/25/2017 Updated 10/02/2026 | |
| Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Baxter Healthcare | Current Available |
— | Posted 10/25/2017 Updated 10/02/2026 | |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: mid-October 2026. Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: mid-October 2026. Check wholesalers for inventory | Posted 02/20/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: late October 2026. Check wholesalers for inventory | Posted 06/13/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 06/13/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 06/13/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 06/13/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 06/13/2018 Updated 10/02/2026 |
| Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release October 2026. Check wholesalers for inventory. | Posted 02/22/2012 Updated 10/15/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release November 2026. Check wholesalers for inventory. | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release October 2026. Check wholesalers for inventory. | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/06/2026 |
| Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 02/22/2012 Updated 10/15/2026 |
| Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 02/22/2012 Updated 10/15/2026 |
| Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 06/13/2018 Updated 10/14/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 06/13/2018 Updated 10/14/2026 |
| Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 06/13/2018 Updated 10/14/2026 |
| Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. | Posted 06/13/2018 Updated 10/14/2026 |
| Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay | Posted 02/22/2012 Updated 10/08/2026 |
| Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 02/22/2012 Updated 10/08/2026 | |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Huons Co., Ltd. (South Korea) | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 07/14/2018 Updated 07/30/2026 |
| Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) | Spectra Medical Devices, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 06/14/2018 Updated 10/08/2026 |
| Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/07/2025 Updated 11/07/2025 Discontinued 11/07/2025 |
| Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/07/2025 Updated 11/07/2025 Discontinued 11/07/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)